The EFHD2 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the EF-hand calcium-binding protein EFHD2. This product provides a heterogeneous pool of HeLa cells with targeted disruption of the EFHD2 gene, enabling researchers to interrogate EFHD2 function without requiring single-cell cloning. The polyclonal format preserves population-level diversity while eliminating the need for monoclonal selection, making it well-suited for functional assays where a mixed knockout background is acceptable or advantageous.
HeLa cells are an immortalized human cervical adenocarcinoma line with a hypertriploid karyotype and integrated HPV18 sequences. Their robust growth, ease of transfection, and extensive characterization have established HeLa as a cornerstone model in cancer biology, virology, and signal transduction research. The multiple chromosomal abnormalities and HPV-driven oncogenic transformation of HeLa cells provide a relevant background for investigating molecular pathways involved in tumorigenesis and metastasis, particularly those intersecting with calcium-mediated signaling and cytoskeletal dynamics.
EFHD2 functions as a calcium sensor that transduces upstream calcium signals into actin cytoskeleton reorganization and cell migration. Upon calcium binding, EFHD2 interacts with adaptor proteins SLP-76 and Vav1, which are critical for coupling immunoreceptor activation to actin polymerization. This interaction promotes actin remodeling and is essential for T cell receptor (TCR)- and Fc??RI-mediated calcium responses, leading to NFAT nuclear translocation and NF-??B activation. Consequently, EFHD2 acts as a central node linking calcium flux to downstream transcriptional programs and mast cell degranulation. Its regulation is responsive to TCR stimulation and antigen receptor crosslinking, positioning EFHD2 at the interface of calcium signaling and cytoskeletal rearrangement.
In the HeLa context, disruption of EFHD2 offers a valuable model for dissecting how calcium-binding proteins contribute to malignant cell behavior. Since HeLa cells exhibit dysregulated actin dynamics and robust migratory capacity, EFHD2 knockout enables analysis of its specific contributions to invasion, adhesion, and metastasis-associated phenotypes. Moreover, the HPV18-positive background provides an environment where viral oncoproteins may intersect with EFHD2-dependent pathways, allowing investigation of crosstalk between viral transformation and host actin-regulatory proteins. The polyclonal nature of this knockout population facilitates bulk biochemical studies and high-throughput screening approaches that benefit from heterogeneous gene disruption.
These EFHD2 knockout cells are suitable for a wide range of experimental applications, including scratch wound healing and transwell migration/invasion assays to assess cell motility, immunofluorescence to visualize actin cytoskeleton alterations, and calcium imaging to evaluate calcium signaling dynamics. Protein interaction studies can be conducted via co-immunoprecipitation with known EFHD2 partners such as SLP-76, Vav1, and actin. Downstream signaling events can be monitored by phospho-signaling analysis, luciferase reporter assays for NFAT or NF-??B activity, and flow cytometry for immune-related markers. This tool supports research in cancer metastasis, autoimmune disorders, allergic inflammation, and Alzheimer??s disease. For further details or to discuss custom modifications, please contact Ascent Research.
